Overview

Carbetocin Versus Ergometrine in the Management of Atonic Post Partum Haemorrhage (PPH) in Women Delivered Vaginally

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
Female
Summary
200 women will be randomly divided into 2 equal groups using computer generated random numbers. Group 1 will receive Carbetocin 100 µgm (Pabal® Ferring, UK) and group 2 will receive ergometrine 0.5mg (methergin®, Novartis, Switzerland).
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Cairo University
Treatments:
Carbetocin
Ergonovine
Oxytocin
Criteria
Inclusion Criteria:

- Women with atonic PPH.

Exclusion Criteria:

- Gestational age <37 weeks.

- Hypertension.

- Preeclampsia.

- Cardiac, renal or liver diseases

- Epilepsy.

- Known hypersensitivity to Carbetocin